Status:
COMPLETED
Evaluation of Bone Mineral Density Indications and Outcomes in Female Adolescents: Implications for Early Detection of Osteopenia/Osteoporosis and Gynecologic Practice
Lead Sponsor:
Bagcilar Training and Research Hospital
Conditions:
Bone Density
Osteopenia
Eligibility:
FEMALE
12-21 years
Brief Summary
This retrospective study evaluates bone mineral density (BMD) measurements obtained by dual-energy X-ray absorptiometry (DEXA) in adolescent girls aged 12 to 21 years at a tertiary care center. The st...
Detailed Description
Adolescence is a critical period for bone mass acquisition, and disturbances during this stage may predispose to osteopenia or osteoporosis in later life. Various clinical conditions encountered in gy...
Eligibility Criteria
Inclusion
- Female adolescents aged 12-21 years
- Underwent bone mineral density (BMD) measurement with DEXA at the study center between 2020 and 2025
- Available clinical and biochemical records, including referral indication
Exclusion
- Incomplete or missing BMD scan data
- Insufficient clinical information in medical records
- Patients with underlying conditions unrelated to bone health that preclude accurate evaluation (e.g., major skeletal deformities interfering with DEXA interpretation)
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT07164248
Start Date
June 1 2025
End Date
August 1 2025
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bagcilar Training and Research Hospital
Istanbul, Turkey (Türkiye), 34200